SCHEMBL10501567

SCHEMBL10501567

O=c1c2cc(Cl)c(Cl)cc2[se]n1-c1nccs1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.38
▸ TDP1 Q9NUW8 3/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ KAT2B Q92831 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ G6PD P11413 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ MPI P34949 1/20 0.38
▸ EP300 Q09472 1/20 0.38
▸ KAT2A Q92830 1/20 0.38
▸ KMT2A Q03164 3/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ PPARG P37231 1/20 0.33
▸ MAPK10 P53779 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ NCOR2 Q9Y618 1/20 0.33
▸ METAP2 P50579 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ APEX1 P27695 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10501845 0.84 KDM4E (0.31) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL5916810 0.83 METAP2 (0.40) ALDH1A1TDP1KDM4EKAT2BGAA
SCHEMBL5916770 0.83 METAP2 (0.40) ALDH1A1TDP1KDM4EKAT2BGAA
SCHEMBL5916643 0.77 MPI (0.44) ALDH1A1TDP1KDM4EKAT2BGAA
SCHEMBL10501508 0.77 METAP2 (0.42) ALDH1A1TDP1KDM4EKAT2BGAA
SCHEMBL10748041 0.77 METAP2 (0.38) ALDH1A1TDP1KDM4EKAT2BMAPT
SCHEMBL5916638 0.76 METAP2 (0.54) ALDH1A1TDP1KDM4EKAT2BGAA
SCHEMBL10502166 0.74 ALDH1A1 (0.39) ALDH1A1TDP1KDM4EKAT2BGAA
SCHEMBL10502494 0.74 TXNRD1 (0.52) ALDH1A1KDM4EKAT2BKMT2ARXFP1
SCHEMBL5916699 0.74 METAP2 (0.46) ALDH1A1KDM4EKAT2BKMT2AMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
Send feedback